Internal Medicine, Rheumatology · Zephyrhills, FL
NPI
1003927500
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
38135 Market Sq Ste 105
Zephyrhills, FL, 33542
Phone (813) 715-1934
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
194,954 services
Medicare patients, 2024
327
Average age 74
Drug cost, 2024
$9.2M
6,184 prescriptions
Company payments, 2025
$1,728
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amarilis Torres was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 65,800 times for 22 patients. In total Amarilis Torres billed 194,954 services in 52 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 65,800 | 22 | $3.61 | $238K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 29,400 | 21 | $8.53 | $251K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 14,543 | 19 | $9.03 | $131K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 12,360 | 26 | $24.92 | $308K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,811 | 73 | $0.10 | $665 |
| J0897 Injection, denosumab, 1 mg | Office | 5,940 | 61 | $20.10 | $119K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 5,100 | 11 | $33.85 | $173K |
| 96372 Injection Administration | Office | 613 | 153 | $10.61 | $6,505 |
| 36415 Venipuncture Blood Collection | Office | 584 | 185 | $8.60 | $5,020 |
| 99214 Office E&M - Established | Office | 386 | 219 | $86.44 | $33K |
| 99213 Office E&M - Established | Office | 338 | 148 | $65.78 | $22K |
| 96413 Chemotherapy Administration | Office | 338 | 58 | $95.69 | $32K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 287 | 53 | $0.47 | $134 |
| 96401 Chemotherapy Administration | Office | 254 | 21 | $53.47 | $14K |
| 96415 Chemotherapy Administration | Office | 182 | 27 | $20.85 | $3,795 |
By year: 2022 $1.9M for 198,828 services; 2023 $1.9M for 206,779 services; 2024 $1.8M for 194,954 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 584 | 185 | $8.60 | $5,020 |
Medicare prescription drug claims, 2024
In 2024, the drug Amarilis Torres prescribed most often to Medicare patients was Meloxicam, with 285 prescriptions and refills. In total Amarilis Torres wrote 6,184 Medicare prescriptions that cost $9.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 285 | 599 | 77 | $1,594 |
| Tramadol Hcl Generic | 270 | 279 | 68 | $2,915 |
| Methotrexate Methotrexate Sodium | 268 | 508 | 63 | $6,739 |
| Oxycodone Hcl Generic | 215 | 215 | 27 | $2,256 |
| Rinvoq Upadacitinib | 210 | 218 | 27 | $1.5M |
| Gabapentin Generic | 204 | 442 | 63 | $4,018 |
| Hydroxychloroquine Sulfate Generic | 194 | 449 | 55 | $8,145 |
| Diclofenac Sodium Generic | 185 | 332 | 54 | $4,072 |
| Alprazolam Generic | 179 | 227 | 47 | $1,331 |
| Prednisone Generic | 170 | 252 | 56 | $1,365 |
| Humira(Cf) Pen Adalimumab | 166 | 174 | 24 | $2.3M |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 158 | 284 | 40 | $1,415 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 130 | 132 | 34 | $2,211 |
| Cyclobenzaprine Hcl Generic | 126 | 201 | 40 | $6,047 |
| Xeljanz Xr Tofacitinib Citrate | 117 | 117 | 14 | $710K |
Brand drugs: 1,146 claims; generic drugs: 4,985 claims; opioid claims: 702.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amarilis Torres $1,728 ($1,728 in general payments such as food, travel and fees) from 12 companies. The largest payer was UCB, Inc. with $509.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.